1. Home
  2. MIRM vs NVEC Comparison

MIRM vs NVEC Comparison

Compare MIRM & NVEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIRM
  • NVEC
  • Stock Information
  • Founded
  • MIRM 2018
  • NVEC 1989
  • Country
  • MIRM United States
  • NVEC United States
  • Employees
  • MIRM N/A
  • NVEC N/A
  • Industry
  • MIRM Biotechnology: Pharmaceutical Preparations
  • NVEC Semiconductors
  • Sector
  • MIRM Health Care
  • NVEC Technology
  • Exchange
  • MIRM Nasdaq
  • NVEC Nasdaq
  • Market Cap
  • MIRM 1.9B
  • NVEC 282.2M
  • IPO Year
  • MIRM 2019
  • NVEC 1996
  • Fundamental
  • Price
  • MIRM $40.00
  • NVEC $57.84
  • Analyst Decision
  • MIRM Strong Buy
  • NVEC
  • Analyst Count
  • MIRM 11
  • NVEC 0
  • Target Price
  • MIRM $58.55
  • NVEC N/A
  • AVG Volume (30 Days)
  • MIRM 447.2K
  • NVEC 29.0K
  • Earning Date
  • MIRM 05-07-2025
  • NVEC 05-05-2025
  • Dividend Yield
  • MIRM N/A
  • NVEC 6.84%
  • EPS Growth
  • MIRM N/A
  • NVEC N/A
  • EPS
  • MIRM N/A
  • NVEC 3.10
  • Revenue
  • MIRM $336,888,000.00
  • NVEC $25,688,208.00
  • Revenue This Year
  • MIRM $29.51
  • NVEC N/A
  • Revenue Next Year
  • MIRM $20.27
  • NVEC N/A
  • P/E Ratio
  • MIRM N/A
  • NVEC $18.27
  • Revenue Growth
  • MIRM 80.76
  • NVEC N/A
  • 52 Week Low
  • MIRM $23.14
  • NVEC $51.50
  • 52 Week High
  • MIRM $54.23
  • NVEC $89.98
  • Technical
  • Relative Strength Index (RSI)
  • MIRM 41.05
  • NVEC 42.40
  • Support Level
  • MIRM $38.22
  • NVEC $55.48
  • Resistance Level
  • MIRM $40.14
  • NVEC $59.31
  • Average True Range (ATR)
  • MIRM 2.24
  • NVEC 3.05
  • MACD
  • MIRM 0.07
  • NVEC 0.26
  • Stochastic Oscillator
  • MIRM 48.50
  • NVEC 61.85

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

About NVEC NVE Corporation

NVE Corp develops and sells devices that use spintronics, a nanotechnology that relies on electron spin. It manufactures high-performance spintronic products including sensors and couplers that are used to acquire and transmit data. The company's products include Digital sensors, Medical sensors, Rotation Sensors, GT Sensors, Angle Sensors, Analog sensors, MSOP Isolators, Passive-In Transceivers, and others. The company manufactures high-performance spintronic products including sensors and couplers. The company's designs are based on giant magnetoresistance GMR and tunneling magnetoresistance TMR combined with integrated circuitry.

Share on Social Networks: